United States v. Aloyisius Juodakis

834 F.2d 1099, 1987 U.S. App. LEXIS 16195, 1987 WL 21158
CourtCourt of Appeals for the First Circuit
DecidedDecember 10, 1987
Docket86-1624
StatusPublished
Cited by43 cases

This text of 834 F.2d 1099 (United States v. Aloyisius Juodakis) is published on Counsel Stack Legal Research, covering Court of Appeals for the First Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Aloyisius Juodakis, 834 F.2d 1099, 1987 U.S. App. LEXIS 16195, 1987 WL 21158 (1st Cir. 1987).

Opinion

PER CURIAM.

Appellant was convicted of conspiracy to manufacture methaqualone. There was abundant evidence and, indeed, defendant admitted that he had at various times helped produce methaqualone. His major arguments on appeal, however, are that there was insufficient evidence of any overt act in furtherance of the charged conspiracy occurring within the five year limitations period prior to the indictment and that he withdrew from the conspiracy prior to the five year limitations period. He also challenges the jury instructions.

Defendant was indicted on November 25, 1985. We review the evidence with particular attention to events after November 25, 1980 to determine whether prosecution was barred by the statute of limitations, 18 U.S.C. § 3282, or whether, instead, as the government contends, overt acts in furtherance of the conspiracy were performed after November 20, 1980 and defendant’s association with it continued into the limitations period.

*1100 There was evidence of the following. According to the testimony (given under immunity) of Gerard Stackhouse, he and one Francis Foley discussed manufacturing drugs sometime in 1976. Thereafter, Stackhouse researched how to produce me-thaqualone, and in 1977 a facility was rented in Worcester, Massachusetts. Foley financed the operation and helped to renovate the place while Stackhouse, along with one Leonard Lewis, tried to produce metha-qualone. Also present doing carpentry work was Tilman Lukas who, although originally unaware of any wrongdoing, guessed something illegal was afoot and was let in on the secret. After nine months to a year of effort, Stackhouse and Lewis succeeded in producing methaqual-one powder. The next step was to turn the powder into tablets. Toward that end, in the spring of 1978, Foley and Stackhouse went to California where they met with Gene Wise and defendant. Defendant, according to his own testimony, had constructed a pill machine for his employer, Wise, and this machine was supplied to Foley and Stackhouse so that they could produce Quaaludes, the pill form of metha-qualone. Stackhouse had trouble with the machine, so in May 1978 defendant went to Massachusetts. Defendant said he got the machine running and helped in other aspects of the Worcester methaqualone operation for about four months. Defendant became uncomfortable, however, because he felt operations were not sufficiently concealed and Foley was ordering chemicals too openly. Consequently, he said, he returned to California in September 1978. During the following twelve months, defendant came to Massachusetts on several errands for Wise, sometimes carrying money to Foley and pills back to Wise.

Meanwhile, the Worcester group had two mishaps. First, in late 1978, they lost their lease. Second, at around the same time, Stackhouse and others (but not Foley) were stopped on their return trip from New York after purchasing there the direct chemical precursors to methaqualone. The agents took the chemicals, but allowed Stackhouse to go. Stackhouse had no further association with Foley’s enterprise after that.

After Stackhouse’s departure, Foley moved the business to South Boston. In June 1979, a building at 377 West First Street, South Boston was acquired and renovations were begun.

Defendant next appeared on the scene in the summer of 1979. Defendant said he returned to Massachusetts at that time and rented an apartment in Hingham (starting September 1, 1979) in order to participate in a venture Foley and Wise were contemplating. The precise nature of the Foley-Wise venture was never decided upon, defendant said, but among the matters discussed was manufacturing the precursors to methaqualone, an operation defendant thought would be perfectly legal. Defendant’s job, he said, was to set up the South Boston space so that it could be used for any number of chemicals, a general purpose facility so to speak. Defendant connected a condenser, checked seals on reactor vessels, and tested equipment, but, he said, never manufactured anything. In December 1979, at a time when defendant was running tests on equipment and wondering what would happen next, Wise was lost at sea. The demise of Wise, whom defendant regarded as his protector, coupled with friction with Foley and defendant’s feeling that he was in over his head with larger equipment than he had ever used before, convinced defendant to leave Massachusetts, he said. On January 15, 1980, he turned in the keys to his Hingham apartment and informed the rental manager he was leaving. The lease was formally terminated April 30, 1980, but the rental manager testified defendant was not in the apartment after January 15,1980. Defendant said he never told Foley about being in over his head for he was afraid Foley would take it badly. Instead, he simply packed and left. After returning to California, defendant put his knowledge to use and made methaqualone himself. There is no contention that defendant’s production of methaqualone in California was part of the conspiracy charged in the indictment.

*1101 In contrast to defendant’s testimony that he left Boston in January 1980, never again to provide any aid to Foley’s business, was the testimony of William Gar-stang. In early 1979, Garstang moved into the house defendant rented in California. Defendant, who shared the residence with Garstang, would be absent from California approximately two weeks out of every six, according to the latter. In the spring of 1980, defendant told Garstang that he was involved in a drug manufacturing operation in Boston or a suburb, that the operation was having difficulties (including management problems), and that he was making curative efforts to try to get the operation to run smoothly and get paid. Defendant’s periodic absences from California did not cease until summer 1980, Garstang said, when defendant and Garstang began manufacturing their own methaqualone in California.

The gas records for the South Boston facility from September 1979 to June 12, 1980 were introduced into evidence. They show a peak usage in January 1980 ($309.70). Thereafter, the bills dropped ($171.95 February; $68.65 March; $57.97 April; $22.25 May), and service was terminated after June 12, 1980 for nonpayment.

There is no direct evidence of what, if anything, transpired at the South Boston site after January 1980 (when defendant says he left) through summer 1980 (when the gas was turned off and defendant’s periodic trips east ceased) through November 25, 1980, the date five years prior to defendant’s indictment. Robert Hanley, the building’s previous owner who had a business next door, said he never saw a sign of life after the renovations.

We now come to events occurring within the limitations period. In late May 1981, Federal Drug Enforcement Administration (DEA) agents searched the South Boston premises. They found a dismantled laboratory. Some, but not all, of the chemicals needed to make methaqualone were present. Samples of residue found in various places along with dust and other sweepings from the floor were taken and analyzed. They were found to contain me-thaqualone and other chemicals from which methaqualone is produced. While the DEA chemist could not say when the lab had last been operative, he felt it indeed had been used to produce methaqualone in view of the methaqualone residue found on the floor and in drawers.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Mejia
First Circuit, 2022
United States v. Lara
970 F.3d 68 (First Circuit, 2020)
United States v. Perez-Couvertier
958 F.3d 81 (First Circuit, 2020)
United States v. Leoner-Aguirre
939 F.3d 310 (First Circuit, 2019)
United States v. Belanger
890 F.3d 13 (First Circuit, 2018)
United States v. Wright
285 F. Supp. 3d 443 (District of Columbia, 2018)
United States v. Ponzo
853 F.3d 558 (First Circuit, 2017)
United States v. Guevara
706 F.3d 38 (First Circuit, 2013)
United States v. Ciresi
697 F.3d 19 (First Circuit, 2012)
United States v. Franco-Santiago
681 F.3d 1 (First Circuit, 2012)
United States v. Diaz
670 F.3d 332 (First Circuit, 2012)
United States v. Lopez-Perez
First Circuit, 2012
State v. Cagno
978 A.2d 921 (New Jersey Superior Court App Division, 2009)
United States v. Fernandez-Torres
604 F. Supp. 2d 356 (D. Puerto Rico, 2008)
United States v. Nieves
322 F.3d 51 (First Circuit, 2003)
United States v. Carey
First Circuit, 2003
United States v. Piper
298 F.3d 47 (First Circuit, 2002)
Jackson v. United States
54 F. App'x 594 (Sixth Circuit, 2001)
United States v. Eck
11 F. App'x 527 (Sixth Circuit, 2001)

Cite This Page — Counsel Stack

Bluebook (online)
834 F.2d 1099, 1987 U.S. App. LEXIS 16195, 1987 WL 21158, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-aloyisius-juodakis-ca1-1987.